Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: SciBase Holding AB

Market Cap 519M 55.09M 47.56M 43.78M 41.04M 76.94M 5.28B 78.14M 202M 2.55B 207M 202M 8.89B P/E Ratio 2026 *
-
P/E Ratio 2027 * -
Enterprise Value 519M 55.09M 47.56M 43.78M 41.04M 76.94M 5.28B 78.14M 202M 2.55B 207M 202M 8.89B EV / Sales 2026 *
7.88x
EV / Sales 2027 * 4.99x
Free-Float
77.17%
Yield 2026 *
-
Yield 2027 * -
1 day+1.60%
1 week+14.16%
Current month+9.48%
1 month+11.65%
3 months+85.40%
6 months+41.11%
Current year+47.25%
1 week 41
Extreme 41
54
1 month 37.5
Extreme 37.5
54
Current year 18.5
Extreme 18.5
54
1 year 18.5
Extreme 18.5
54
3 years 18.5
Extreme 18.5
148.4
5 years 18.5
Extreme 18.5
657
10 years 18.5
Extreme 18.5
3,020
Manager TitleAgeSince
Chief Executive Officer 59 01/10/2023
Director of Finance/CFO 64 01/01/2014
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 16/05/2017
Chairman 65 13/06/2024
Director/Board Member 68 -
Change 5-day change 1-year change 3-year change Capi.($)
+1.60%+14.16%+32.98%-59.29% 53.93M
-2.50%-5.57%+10.45%-29.84% 16.91B
+6.03%-1.29%+30.18%+60.84% 1.57B
-0.32%0.00%-30.18%+19.55% 1.12B
+4.37%+3.60%-54.43%-83.37% 921M
-1.20%-5.89%-25.62%-55.23% 643M
-0.07%-5.93%-47.62%-59.63% 561M
+4.75%+8.67%+23.79%-51.45% 444M
+0.47%-1.09%-55.54%-60.17% 390M
+4.62%-5.64%+48.36% - 324M
Average +1.78%+0.86%-6.76%-35.40% 2.29B
Weighted average by Cap. -1.14%-2.26%+4.51%-25.76%

Financials

2026 *2027 *
Net sales 65.9M 6.99M 6.03M 5.55M 5.21M 9.76M 669M 9.91M 25.61M 323M 26.24M 25.67M 1.13B 104M 11.05M 9.54M 8.78M 8.23M 15.43M 1.06B 15.68M 40.49M 511M 41.49M 40.59M 1.78B
Net income -66.3M -7.03M -6.07M -5.59M -5.24M -9.82M -673M -9.97M -25.76M -325M -26.4M -25.83M -1.13B -51.5M -5.46M -4.71M -4.34M -4.07M -7.63M -523M -7.75M -20.01M -253M -20.5M -20.06M -881M
Net Debt - -
Logo SciBase Holding AB
SciBase Holding AB (publ) is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. SciBase Holding AB (publ) specializes in early detection and prevention in dermatology. The Company develops and commercializes Nevisense, a point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. SciBase Holding AB (publ) combines advanced EIS technology with AI to empower healthcare professionals by improving diagnostic precision, facilitating disease monitoring, and enabling early detection of skin cancer.
Employees
49
Date Price Change Volume
11/06/26 50.80 kr +1.60% 2,799
10/06/26 50.00 kr +1.63% 8,492
09/06/26 49.20 kr +0.41% 30,687
08/06/26 49.00 kr +12.39% 18,849
05/06/26 43.60 kr +1.02% 2,457

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCIB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!